Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies

OBJECTIVES: In the EINSTEIN DVT and EINSTEIN PE studies, the majority of patients received heparins to bridge the period during venous thromboembolism (VTE) diagnosis confirmation and the start of the study. In contrast to vitamin K antagonists (VKAs), rivaroxaban may not require initial heparin tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Prandoni, Paolo, Prins, Martin H., Cohen, Alexander T., Müller, Katharina, Pap, Ákos F., Tewes, Miriam C., Lensing, Anthonie W. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024063/
https://www.ncbi.nlm.nih.gov/pubmed/25676529
http://dx.doi.org/10.1111/acem.12585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024063/
https://www.ncbi.nlm.nih.gov/pubmed/25676529
http://dx.doi.org/10.1111/acem.12585

Ejemplares similares